Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568425 · ClinicalTrials.gov registry record
QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00568425: Clinical Trial study, sponsored by Stanford University.
NCT00568425 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568425 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is show that intensity-modulated radiotherapy (IMRT), as compared with conventional radiotherapy, improves the precision of tumor targeting and reduces the acute and late effects of radiation toxicity when used to treat anal cancer. Results from this work will provide a basis for incorporating the use of IMRT to treat anal cancer in future treatment protocols.
Primary Outcome
Quality of life questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-09 |
Why NCT00568425 stopped before completion
NCT00568425 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00568425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00568425 about?
NCT00568425 is a clinical study titled "QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT". The purpose of this study is show that intensity-modulated radiotherapy (IMRT), as compared with conventional radiotherapy, improves the precision of tumor targeting and reduces the acute and late effects of radiation toxicity when used to treat anal cancer. Results from this work will provide a bas...
What is the current status of trial NCT00568425?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2005-09. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT00568425?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia